Kappa Bioscience

About us

At Kappa Bioscience we are proud to offer you high purity vitamin K2 as menaquinone-7 (MK-7).  As the innovative leader and first mover of vitamin K2 MK-7, we have extensive knowledge about vitamins and are currently the only vendor with vitamin K2 as pure MK-7 in various formulations. Based on the self-affirmed GRAS approval, our K2 MK-7 can also be used in conventional foods.

Founded in December 2006, Kappa Bioscience is a Norwegian based entity that takes pride in following a traditional vitamin production process with propriety and innovative new steps.  One of our core assets is the patent covering the production of pure vitamin K2 as menaquinone‑7.

Our main focus is to develop vitamin K2 for the food supplement and fortified foods market.

Vitamin K2 is currently gaining momentum across the world and as it does, we intend to continue to serve the market with pure and stable forms of MK-7 products.

All of our products have been developed in close collaboration with highly qualified Norwegian and international scientists, who have been able to successfully accomplish the difficult process of producing menaquinone-7.

We are proud to launch the first man-made menaquinone-7 in its natural form - as K2VITAL®.

  • Our research is conducted globally
  • Production is established in Europe
  • Marketing and sales activities are managed from Germany.


Our Vision

Kappa Bioscience has the vision to making vitamin K2 available to everybody, everywhere.


Mission statement

We believe our product – Vitamin K2 MK-7 and our mission is to provide everyone from manufacturers to consumers with a pure, reliable and safe product.  We take pride in delivering everyone with a quality product for improving health.


Our values

The company values shall guide each individual employee’s behavior and be the basis for creating a transparent and collaborative company culture.  Kappa Bioscience’s core values are:

Bravery / Openness / Activeness


We are committed to educating the industry about the many benefits of vitamin K2 MK-7 for health. Read our latest presence in the media below:

  • Company
  • Vitamin K2

Kappa Bioscience extends Research Partnership for COVID-19 trial

More Information

Kappa Bioscience announces US expansion plans

More Information

Kappa Bioscience enters research collaboration with US University Hospitals

More Information

Kappa receives Vegan certification for its K2VITAL and CAS ingredients

More Information

Kappa Bioscience launches Perfect Pair programme and new K2 Formulation LookBook

More Information

Kappa Bioscience receives new K2 MK-7 production process patent

More Information

K2VITAL® receives Chinese and Mexican regulatory approvals

More Information

USP update reflects growth of stability-enhanced vitamin K2 products

More Information

Research team aims to explore Vitamin K2 MK-7 impact on COVID-19 - trial funded by Kappa Bioscience

More Information

Researchers flag link between Vitamin K status and COVID-19 mortality risk

More Information

Vitamin D and COVID-19: why Vitamin K2 should be at the heart of high-dose supplementation

More Information

Review suggests Vitamin K as the potential 'missing link' in COVID-19

More Information

Vitamin D and K status linked to reduced mortality risk, say researchers

More Information

The Perfect Pair: Vitamins K2 and D3 synergy shown to amplify effects of both

More Information

Vitamins D3 & K2: The Perfect Pair
K2VITAL infographic

More Information

Dietary supplements, active ingredients and adulteration: a Vitamin K2 example

More Information

Vitamin K2: organic synthesis vs. fermentation

More Information

Too many unprotected K2+minerals products are sold to consumers, says Kappa Bioscience

More Information


Egil Greve

President and CEO

Egil is an entrepreneur with broad executive experience from building up companies and business units within the multinational companies Norsk Hydro ASA, Yara International ASA and AKZO Nobel. He also headed several SMBs including NattoPharma ASA before he was asked to build up Kappa Bioscience in 2009.


Kai Schröder

VP Finance & Operations
MSc (Management & Economics), INSEAD EMP

Kai is an executive with experience from international companies such as GE Healthcare, Philip Morris International and Porsche in functions ranging from Manufacturing & Supply Chain to General Management. He accumulated extensive know-how in the areas of Managing P&Ls, Commercial Management and Leadership, Finance and Strategy as well as Sales & Operations Planning.


Trygve Bergeland

VP Science & Product Development

Trygve has a broad experience in research and documentation within the nutraceutical and pharmaceutical industry. Before joining Kappa Bioscience, Trygve was responsible for the clinical documentation program in Aker BioMarine. He has generated extensive experience from management of clinical research in Clavis Pharma and LINK Medical Research.


Inger Reidun F. Aukrust

Vice President R&D & Chemistry
PhD in Organic Chemistry

More than 25 years of experience within medicinal chemistry and custom synthesis from SINTEF and Synthetica. Founder of Synthetica and Kappa Bioscience.


Jörg Büttinghaus

Vice President Sales

Jörg is responsible for the groups global sales and marketing organization. He has been a member of the nutraceutical industry for more than 15 years, during which time he was involved in the introduction of several successful specialities including PressCAL®, AlgaeCal®, NEM®, Calcified Atlantic Seaweed® and K2VITAL®.


Jon Erik Brænden

Vice President Production

Jon Erik is responsible for the production, and holds a PhD in organic chemistry. Before joining Kappa Bioscience he has been 25 years in the pharmaceutical industry, responsible for documentation, product and process development of active pharmaceutical ingredients, within the area of contrast agents, cancer, analgesics (opioids) and diabetes. 


Henriette Bastiansen

Vice President Quality & Regulatory
Master in Food Science & Technology

Henriette is responsible of the global quality management and regulatory affairs. She holds a Master’s degree and worked for global companies such as Colgate-Palmolive, Mondelez International, Chr Hansen and Kevin Murphy. She gained a broad experience in developing and implementing regulatory strategies, evaluating the compliance of product content, specifications, labeling and registrations and quality management.


Dominik Mattern

Vice President Marketing
MSc in Food Chemistry

Dominik is a leader with 20 years of progressive experience in the nutraceutical industry and is spearheading marketing at Kappa Bioscience. Dominik is known for his pioneering approach to commercial models and product innovation. Passionate for business ethics and sustainability, he is a staunch supporter of the triple-bottom-line: people-planet-profit. Before Kappa, Dominik has served in international companies such as SwissCaps, Capsugel and Lonza.  



The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process.

The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential. Commercially available vitamin K2 products may contain both forms.



Kappa is proud to work and collaborate with the leading nutritional supplements distributors in regions that span the globe. We invite you to contact our distributors directly to learn about K2VITAL® and the Kappa product portfolio, or contact Kappa directly and we will make an introduction.

DistributorCountryRegioOperative in charge
PathwayAustralia and New ZealandAsiaMr Wayne Coote (Email)
SA PharmachemIndiaAsiaMs Mayuri Musham (Email)
ConnellBangladeshAsiaMs Saadia Aleema Hoque (Email)


VietnamAsiaMs. Thi (Pharma) (Email)
Ms. Phoi (Food) (Email)
Epic IngredientsMalaysiaAsiaMr Jeffrey Aw (Email)
Connell BrosTaiwanAsiaMs Irene Hsueh (Email)
PhytonetPhilippinesAsiaMrs Helen Grace Basia (Email)
Velpha ChemicalsPakistanAsia

Mr Ali Hassni (Email)

PhytonetKoreaAsiaMr Allen Lee (Email)
Rama ProductionThailandAsiaMs Prakaithip Ekwongsupasarn (Email)

Shanghai Toong Yeuan Food Tech Ltd.
Shanghai Toong Yeuan Healthcare Tech Ltd.

ChinaAsiaSteven Wang (Email)
PT TatarasaIndonesiaAsiaMr Soekiandi Ali (Email)
Zifroni ChemicalsIsraelMiddle EastRafi Zifroni (Email)
TFS GroupRussiaEurope/ AsiaIlya Okhotin (Email)
FaravelliItalyEuropeTiziana Ferrari (Email)
KUKEastern EuropeEuropeStephan Wohlrab (Email)
PhytonetTurkeyEuropeSelim Ay (Email)
VITA NOVA-ZABalkanEuropeZagorka Blazevska (Email)
Safic AlcanSpainEuropeMercedes Carillo (Email)
Safic AlcanFrance + MoroccoEuropeCharlotte Delarue (Email)
KUKBaltic + GreeceEuropeLīga Eglīte​ (Email)
Solo GroupSouth AfricaAfricaDean Hall (Email)
BiochimexAlgeria + TunisiaAfricaChristielle Dupain (Email)
AIDPUSAAmericaMark Thurston (Email)
RJR Nutrientes e Farmoquímicos Ltda.BrazilAmericaFelipe Simões (Email)
Safe Iberoamericana S.A. de C.V.MexicoAmericaJorge Cabeiro (Email)
Deltagen SAS.ColombiaAmericaPaul Agudelo (Email)

Customer Download Portal

Sign up | Reset password

Sales and Marketing
Kappa Ingredients GmbH
Friesenweg 4 | Building 13 | 22763 Hamburg

Kappa Bioscience AS
Silurveien 2 | Building B | 0380 Oslo

+49 40 6094087 0
Sales team USA: +1 609 201 1459